|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | An efficient microwaveassisted synthesis and biological properties of polysubstituted pyrimidinyl and 1, 3, 5 -triazinylphosphonic acids 显示文摘 | Jansa P Hradil 0 Baszczy nki 0 | 2012 | Tetrahedron2012，68，3： | 1 |
| 2 | Pulmonary arterial hypertension-contemporary management strategy 显示文摘 | Jansa P Ambroz D Maresova J | 2009 | Bratisl Lek List2009，110，10： | 1 |
| 3 | Bosentan for treat- ment of inoperable chronic thromboembolic pulmonary hyper- tension: BENEFIT( Bosentan Effects in iNopErable Forms of chronic Thromboembolic pulmonary hypertension ), a ran- domized, placebo-controlled trial 显示文摘 | JAIS X D'ARMINI A M JANSA P | 2008 | J Am Coil Cardiol2008，52，： | 1 |
| 4 | Long- term experience with trerpostinil infusion treatment in patients with pulmonary arterial hypertension in the Czech Republic显示文摘 | JANSA P AMBROZ D MARESOVA J | 2007 | Vnitr Lek2007，53，4： | 1 |
| 5 | Treatment of patients with mildly symptomatic pulmonary arterial hypertension with bosentan (EARLY study): a double-blind, randomised controlled trial显示文摘 | N Galiè LJ Rubin MM Hoeper P Jansa H Al-Hiti GMB Meyer E Chiossi A Kusic-Pajic G Simonneau | 2008 | The Lancet2008，，9630： | 1 |
| 6 | Contemporary prospects for the diagnostics and treatment of the chronic pulmonary hypertension显示文摘 | Jansa P Aschermann M Lindner J | 2006 | Cas Lek Cesk2006，145，4： | 1 |
| 7 | Drug therapy of pulmonary arterial hypertension in 2014显示文摘 | Aschermann M Jansa P | 2014 | Vnitr Lek2014，60，4： | 1 |
| 8 | Drug therapy of pulmonary arterial hyper- tension in 2014显示文摘 | Aschermann M Jansa P | 2014 | Vnitrni lekarstvi2014，60，4： | 1 |
| 9 | Efficient and‘ green’microwave-assisted synthesis of haloalkylphosphonates via themichaelis–arbuzov reaction显示文摘 | Jansa P Holy A Dra-insky M | 2011 | Green Chemistry2011，13，88： | 1 |
| 10 | Pulmonary arterial hypertension2- contemporary management strategy显示文摘 | Jansa P AmbrozD Maresova J | 2009 | Bratisl Leklisty2009，110，10： | 1 |
| 11 | Pulmonary arterial hyperten- sion--contemporary management strategy 显示文摘 | Jansa P Ambroz D Maresova J | 2009 | Bratisl Lek Listy2009，110，10： | 1 |
| 12 | No significant contribution ofarbuscular mycorrhizal fungi to transfer of radiocesium from soil toplants 显示文摘 | JONER E J ROOS P JANSA J | 2004 | Applied and Environmental Microbiology2004，70，11： | 1 |
| 13 | Pulmonary arterialhypertension-contemporary management strategy显示文摘 | Jansa P Ambroz D Maresova J | | 0，，10： | 1 |
| 14 | Bosentan for treatment of inoperable chronic thromboembolic pulmonary hypertension:BENEFiT (Bosentan Effects in iNopErable Forms of chronIc Thromboembolic pulmonary hypertension),a randomized,placebocontrolled trial显示文摘 | Ja(1)s X D'Armini AM Jansa P | 2008 | J Am Coll Cardiol2008，52，： | 1 |
| 15 | Treatment of patients with mildly symptomatic pulmonary arterial hypertension with bosentan (EARLY study): a double-blind, randomised controlled trial显示文摘 | N Galiè LJ Rubin MM Hoeper P Jansa H Al-Hiti GMB Meyer E Chiossi A Kusic-Pajic G Simonneau | 2008 | 2008 (9630)2008，，9630： | 1 |
| 16 | Cloning and functional characterization of PTRF, a novel protein which induces dissociation of paused ternary transcription complexes 显示文摘 | Jansa P Mason SW Hoffmann-Rohrer U | 1998 | EMBO J1998，17，10： | 1 |
| 17 | Bosentan for treatment of inoperable chronic thromboembolic pulmonary hypertension: BENEFIT (Bosentan Effects in iNopErable Forms of Chronic Thromboembolic pulmonary hypertension), a randomized, placebo- controlled trial显示文摘 | Jais X D'Armini AM Jansa P | 2008 | J Am Coll Cardiol2008，52，25： | 1 |
| 18 | Chronicthromboembolic pulmonary hypertension: role of medicaltherapy显示文摘 | Pepke-Zaba J Jansa P Kim NH | 2013 | Eur Respir J2013，41，4： | 1 |
| 19 | Pulmonary arterial hy-pertension-contemporary management strategy显示文摘 | Jansa P’Ambroz D Maresova J | 2009 | Bratisl LekListy2009，110，10： | 1 |
| 20 | Takotsubo eardiomyopathy : case report and literature review显示文摘 | Paleeek T Linhart A Jansa P | 2005 | Cas Lek Cesk2005，144，6： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员